• APOL1-Mediated Kidney Disease (AMKD) Rare360 Perspectives, Insights & Experiences (P.I.E)

    Subscribe to the Rare360 P.I.E. Program to stay updated on resources, research developments, and opportunities available to individuals and families affected by APOL1-Mediated Kidney Disease (AMKD).
  • The goal is to identify the global prevalence of APOL1-Mediated Kidney Disease (AMKD) to better understand the impact of this rare disease and the needs of the APOL1-Mediated Kidney Disease (AMKD) community.

    Have any questions? Please email us at admin@rare360.life.

  • Choose all of the following options that best describe you:*
  • How long ago were you diagnosed with APOL1-Mediated Kidney Disease (AMKD)?*
  • How long ago was your loved one diagnosed with APOL1-Mediated Kidney Disease (AMKD)?*
  • Please select the age group that fits your current age*
  • What was your biological classification at birth?*
  • What is your racial classification? Select ALL that apply*
  • What is your ethnicity? Select ALL that apply.*
  • Which category BEST describes the highest level of education that you have acquired? Select ONE answer*
  • Do you consent to be contacted by Rare360, powered by the Rare Advocacy Movement (RAM)?*
  • Format: 0000000000.
  • Should be Empty: